Dramatically improved neurological deficits, reduced brain water contents and infarct sizes at 24 h after stroke and attenuated the over-expression of HMGB1, RAGE, TLR4, and NF-κB induced by ischemia. The gene discussed is NFKB1; the disease is stroke disorder.